Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IIFL Capital is a prominent Indian financial services conglomerate that operates as a key player in the investment banking and asset management sectors. While not a biotechnology or pharmaceutical developer itself, the firm is deeply integrated into the healthcare ecosystem as a significant provider of growth capital and private equity. Through its dedicated healthcare and life sciences funds, IIFL Capital invests in a diverse range of companies, including pharmaceutical manufacturers, hospital networks, and medical technology providers. The firm's activities facilitate the expansion and modernization of healthcare infrastructure and drug development capabilities within the Indian market. IIFL Capital also provides strategic advisory services for mergers, acquisitions, and public listings for healthcare entities. Notable investments include stakes in companies such as Neuland Laboratories and Sahajanand Medical Technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IIFL Capital.